Diabetes Mellitus Clinical Trial
Official title:
"Outcome of Diabetes Education Among Renal Transplant Recipients With New Onset Diabetes After Transplantation (NODAT)"
Introduction:
Diabetes is a chronic disease that requires lifelong self care behavior. Successful treatment
of chronic diseases is closely associated with the education of both patients and their
relatives. Patient education is one of the most important responsibilities of diabetes nurse
educators. In the management of diabetes, helping patients to improve their health and
quality of life is considered an important aspect of diabetes self-care education. Solid
organ transplantation is now the standard of care for end-stage organ failure. New-onset
diabetes mellitus after solid organ transplantation (NODAT) has emerged as an increasingly
important determinant of outcomes and survival in transplant recipients. Patient education
and self-management are crucial for ensuring successful outcome post transplantation. No
adequate studies concerning education of diabetic renal transplants.
Aim of the work: The aim of this work is to evaluate the effect of diabetes education given
to renal transplant recipients with new onset diabetes after transplantation (NODAT) on their
self-care activities and metabolic control variables and reversibility of the present chronic
diabetic complications.
Patients and methods:
The study will involve 210 diabetic renal transplant patients (NODAT) who will be referred
from Hamed Al-Essa organ transplant center to Dasman Diabetes Institute. These patients will
be sub-divided into three subgroups: patients who will receive group education (n=70) will
represent group1, patients who will receive one to one education (n=70) will represent group
2, while those who will receive the conventional (not structured) education program will
serve as control group 3(n= 70). All patients of group 1 and 2 will receive intensive
education for 3-4 months, then refreshment session every 3 months for 2 years. Initially,
patient data will be collected through 3 types of forms: patient identification form,
metabolic control parameters form and diabetes self-care scale questionnaire; then every 6
months metabolic parameters and diabetes self-care scale questionnaire will be reassessed.
Expected outcome: Patient education given to transplant recipients with NODAT could affect
patients' self-care activities, metabolic control positively and possibly help in reversal of
chronic diabetic complications
The research population will include organ transplant recipients with NODAT who are followed
up in Hamed AL-Essa organ transplant centre of Kuwait and who will meet the eligibility
criteria. Two hundred and ten diabetic renal transplant recipients will be enrolled in this
prospective randomised controlled study. Patients who fulfil the following criteria will be
included in the study: 1) transplant duration more than 6 months; 2) being an outpatient; 3)
not having any psychiatric history of illness; 4) written consent to participate in the
research; and 5) age of diabetic patients more than 21 years . We will exclude paediatrics
(bellow 21 years) and mentally abnormal patients. Ethical principles of the research Written
permission will be received from the institutions where the research will be carried out.
Information form including the aim and scope of the research will be submitted to Ethical
Committees of both ministry of health (MOH) of Kuwait and Dasman Diabetes Institute.
Data collection tools
Patient identification form:
This form will include information about the patient's identifying characteristics such as
age, gender, education status and disease-related information such as duration of the disease
and the treatments management of diabetes.
Metabolic control parameters form:
This form will include patient's metabolic control variables such as HbA1c, lipids (Total
cholesterol, triglyceride, high-density lipoprotein (HDL), low-density lipoprotein (LDL),
renal and liver function tests. Metabolic control parameters will be measured in Hamed
Al-Essa organ transplantation center (OTC) outpatient clinic and will be sent with each
patient to Dasman Diabetes Institute within one week of patient evaluation for starting
educational program.
Blood pressure, height, weight, body mass index and waist circumference of patients will be
measured and recorded by the researcher each time by using the same measurement device and
method. Patients' waist circumferences will be measured midway between costal margin and
iliac crests by a measuring tape in standing position, over underwear and after slight
expiration.
Diabetes self-care scale (DSCS) The Arabic translated 24-items scale- developed in English by
Lee and Fisher(41) which measures the self care of patients with diabetes -will be applied to
patients before and after the education program.
Data collection method In the pretest phase of the research, patients will be given a patient
identification form, metabolic control parameters form and a DSCS. The forms will be
completed within15-25 minutes by the patients in the presence of the researcher. Telephone
numbers and addresses of patients will be taken for proper communication if needed.
Patient education Group education sessions will be carried out in special halls in Dasman
Diabetes Institute (DDI) after proper coordination with the randomly selected patients (group
1) (6-10 patients in each education group). Patients of one to one education group (group 2)
will receive education sessions individually in closed education clinics of DDI. The first
session will last for 60 minutes then the next sessions will last for 30 minutes. The content
of education will be repeated entirely or partly by the researcher according to each
patient's needs. Mixed education techniques such as description, question and answer
techniques will be used as an education method and feedback will be stimulated trying to
enable patients to understand their self-care management independently. Refreshment education
sessions will be delivered every 3 months later on till the end of the study.
Regarding patients of the third group (control group), each patient will receive the
conventional (non-structured) education program in their mother hospital (OTC).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |